Filed: 8/12/2025ACC: 0001843547-25-000009
📋 What this filing means
VANTAGE CONSULTING GROUP INC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $5.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$5.73M
Total AUM (reported)
4.24M
Total Shares
Allocation by class
COM$5.73M100.0%
Portfolio Concentration
Top 3$5.73M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.24M
Sole
Full voting authority
4.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Babcock & Wilcox Enterprises Inc.
SOLEShares2.42M
TypeSH
Market value$2.32M
40.54%
Sole
2.42M
Shared
0.00
None
0.00
ADC Therapeutics SA
SOLEShares683K
TypeSH
Market value$1.83M
31.92%
Sole
683K
Shared
0.00
None
0.00
Cibus, Inc.
SOLEShares1.14M
TypeSH
Market value$1.58M
27.53%
Sole
1.14M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Babcock & Wilcox Enterprises Inc.SOLE | COM | 2.42M | SH | $2.32M 40.54% | 2.42M | 0.00 | 0.00 |
ADC Therapeutics SASOLE | COM | 683K | SH | $1.83M 31.92% | 683K | 0.00 | 0.00 |
Cibus, Inc.SOLE | COM | 1.14M | SH | $1.58M 27.53% | 1.14M | 0.00 | 0.00 |